[Public Notices]2022 KDDF-SNU Science Conference / Poster
2 Sep 2022
[Public Notices]2022 KDDF-SNU Science Conference / Poster
2F, Research Building 2, 70,
Yuseong-daero 1689 beon-gil,
Yuseong-gu, Daejeon, 34047, Republic of Korea
HQ +82-42-863-2017
R&D Center +82-42-861-2017
Investor Relations +70-4294-6097
FAX +82-42-863-2080
COPYRIGHT BY PharmAbcine Inc.
ALL RIGHTS RESERVE
2022 KDDF (Korea Drug Development Fund) - SNU (Seoul National University)
Dr. Jin-San Yoo, CEO of PharmAbcine, delivered a poster presentation on the nonclinical data of the company’s early-stage anti-EGFRviii antibody (PMC-005) between August 25th and 27th.
> The image below is the nonclinical data of PMC-005.
■ Posters for other pipelines are available for viewing.
1. 2022 KDDF-SNU_Olinvacimab mTNBC clinical trial poster Poster
2. 2022 KDDF-SNU_PMC-309 Poster
3. 2022 KDDF-SNU_PMC-403_Oncology Poster
4. 2022 KDDF-SNU_PMC-403_ophthalmology Poster
5. 2022 KDDF-SNU_PMC-001 Poster
6. 2022 KDDF-SNU_PMC-201 Poster